References
- Horcajada P, Gref R, Baati T, et al. Metal–organic frameworks in biomedicine. Chem. Rev. 2012;112(2):1232–1268. doi:https://doi.org/10.1021/cr200256v.
- Kotzabasaki M, Froudakis GE. Review of computer simulations on anti-cancer drug delivery in MOFs. Inorg. Chem. Front. 2018. doi:https://doi.org/10.1039/C7QI00645D
- Cai H, Huang Y-L, Li D. Biological metal–organic frameworks: structures, host–guest chemistry and bio-applications. Coord. Chem. Rev. 2019;378:207–221. doi:https://doi.org/10.1016/j.ccr.2017.12.003.
- Horcajada P, Serre C, Vallet-Regí M, et al. Metal–organic frameworks as efficient materials for drug delivery. Angew. Chemie Int. Ed. 2006;45(36):5974–5978. doi:https://doi.org/10.1002/anie.200601878.
- Horcajada P, Serre C, Maurin G, et al. Flexible porous metal-organic frameworks for a controlled drug delivery. J. Am. Chem. Soc. 2008;130(21):6774–6780. doi:https://doi.org/10.1021/ja710973k.
- Imaz I, Rubio-Martínez M, García-Fernández L, et al. Coordination polymer particles as potential drug delivery systems. Chem. Commun. 2010;46(26):4737–4739. doi:https://doi.org/10.1039/C003084H.
- Taylor-Pashow KML, Della Rocca J, Xie Z, et al. Postsynthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug delivery. J. Am. Chem. Soc. 2009;131(40):14261–14263. doi:https://doi.org/10.1021/ja906198y.
- Horcajada P, Chalati T, Serre C, et al. Porous metal–organic-framework nanoscale carriers as a potential platform for Drug Delivery and imaging. Nat. Mater. 2009;9:172.
- Sikora BJ, Winnegar R, Proserpio DM, et al. Textural properties of a large collection of computationally constructed MOFs and zeolites. Microporous Mesoporous Mater. 2014;186:207–213. doi:https://doi.org/10.1016/j.micromeso.2013.11.041.
- Wilmer CE, Leaf M, Lee CY, et al. Large-scale screening of hypothetical metal–organic frameworks. Nat. Chem. 2011;4:83.
- Bernales V, Ortuño MA, Truhlar DG, et al. Computational design of functionalized metal–organic framework nodes for catalysis. ACS Cent. Sci. 2018;4(1):5–19. doi:https://doi.org/10.1021/acscentsci.7b00500.
- Orellana-Tavra C, Baxter EF, Tian T, et al. Amorphous metal-organic frameworks for drug delivery. Chem. Commun. 2015;51(73):13878–13881. doi:https://doi.org/10.1039/C5CC05237H.
- Férey G, Mellot-Draznieks C, Serre C, et al. A chromium terephthalate-based solid with unusually large pore volumes and surface area. Science (80-.). 2005;309(5743):2040–2042.
- Küsgens P, Rose M, Senkovska I, et al. Characterization of metal-organic frameworks by water adsorption. Microporous Mesoporous Mater. 2009;120(3):325–330. doi:https://doi.org/10.1016/j.micromeso.2008.11.020.
- Burtch NC, Jasuja H, Walton KS. Water stability and adsorption in metal-organic frameworks. Chem. Rev. 2014;114(20):10575–10612. doi:https://doi.org/10.1021/cr5002589.
- Markopoulou P, Panagiotou N, Li A, et al. Identifying differing intracellular cargo release mechanisms by monitoring in vitro drug delivery from MOFs in real time. Cell Reports Phys. Sci. 2020;1(11):100254), doi:https://doi.org/10.1016/j.xcrp.2020.100254.
- Wuttke S, Braig S. MOF nanoparticles coated by lipid bilayers and their uptake by cancer cells. Chem. Commun. 2015;51(87):15752–15755. doi:https://doi.org/10.1039/C5CC06767G.
- Wuttke S, Zimpel A, Bein T, et al. Validating metal-organic framework nanoparticles for their nanosafety in diverse biomedical applications. Adv. Healthc. Mater. 2017;6(2). doi:https://doi.org/10.1002/adhm.201600818
- Liu C-H, Chiu H-C, Sung H-L, et al. Acute oral toxicity and repeated dose 28-Day oral toxicity studies of MIL-101 nanoparticles. Regul. Toxicol. Pharmacol. 2019;107; doi:https://doi.org/10.1016/j.yrtph.2019.104426.
- Kotzabasaki M, Galdadas I, Tylianakis E, et al. Multiscale simulations reveal IRMOF-74-III as a potent drug carrier for gemcitabine delivery †. J. Mater. Chem. B. 2017;5:3277. doi:https://doi.org/10.1039/c7tb00220c.
- Colón YJ, Snurr RQ. High-throughput computational screening of metal–organic frameworks. Chem. Soc. Rev. 2014;43(16):5735–5749. doi:https://doi.org/10.1039/C4CS00070F.
- Greathouse JA, Ockwig NW, Criscenti LJ, et al. Computational screening of metal–organic frameworks for large-molecule chemical sensing. Phys. Chem. Chem. Phys. 2010;12(39):12621), doi:https://doi.org/10.1039/c0cp00092b.
- Erucar I, Keskin S. Efficient storage of drug and cosmetic molecules in biocompatible metal organic frameworks: a molecular simulation study. Ind. Eng. Chem. Res. 2016;55(7):1929–1939. doi:https://doi.org/10.1021/acs.iecr.5b04556.
- Bernini MC, Fairen-Jimenez D, Pasinetti M, et al. Screening of bio-compatible metal-organic frameworks as potential drug carriers using Monte Carlo simulations. J. Mater. Chem. B. 2014;2(7):766–774. doi:https://doi.org/10.1039/C3TB21328E.
- Gomar M, Yeganegi S. Adsorption of 5-fluorouracil, hydroxyurea and Mercaptopurine drugs on Zeolitic Imidazolate frameworks (ZIF-7, ZIF-8 and ZIF-9). Microporous Mesoporous Mater. 2017;252:167–172. doi:https://doi.org/10.1016/J.MICROMESO.2017.06.010.
- Sun C-Y, Qin C, Wang X-L, et al. Zeolitic Imidazolate framework-8 as efficient PH-sensitive drug delivery vehicle. Dalt. Trans. 2012;41(23):6906–6909. doi:https://doi.org/10.1039/C2DT30357D.
- Djukanović R, Wilson JW, Britten KM, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am. Rev. Respir. Dis. 1992;145(3):669–674. doi:https://doi.org/10.1164/ajrccm/145.3.669.
- Ericson-Neilsen W, Kaye AD. Steroids: pharmacology, complications, and practice delivery issues. Ochsner J. 2014;14(2):203–207.
- Ference JD, Last AR. Choosing topical corticosteroids. Am. Fam. Physician. 2009;79(2):135–140.
- Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J. Invest. Dermatol. 1952;19(2):101–102.
- Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma. Clin. Immuno. 2013;9(1):30), doi:https://doi.org/10.1186/1710-1492-9-30.
- Uva L, Miguel D, Pinheiro C, et al. Mechanisms of action of Topical Corticosteroids in psoriasis. Int J Endocrinol. 2012;16; doi:https://doi.org/10.1155/2012/561018.
- Takeda K, Arase S, Takahashi S. Side effects of Topical Corticosteroids and their prevention. Drugs. 1988;36(5):15–23. doi:https://doi.org/10.2165/00003495-198800365-00005.
- Balzus B, Sahle FF, Honzke S, et al. Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium. Eur. J. Pharm. Biopharm. 2017;115:122–130. doi:https://doi.org/10.1016/j.ejpb.2017.02.001.
- Giulbudagian M, Hönzke S, Bergueiro J, et al. Enhanced topical delivery of dexamethasone by β-cyclodextrin decorated thermoresponsive nanogels. Nanoscale. 2018;10(1):469–479. doi:https://doi.org/10.1039/C7NR04480A.
- Babarao R, Jiang J. Unraveling the energetics and dynamics of Ibuprofen in Mesoporous metal−organic frameworks. J. Phys. Chem. C. 2009;113(42):18287–18291. doi:https://doi.org/10.1021/jp906429s.
- Akkermans RLC, Spenley NA, Robertson SH. Monte Carlo methods in materials studio. Mol. Simul. 2013;39(14–15):1153–1164. doi:https://doi.org/10.1080/08927022.2013.843775.
- Daglar H, Keskin S. Recent advances, opportunities, and challenges in high-throughput computational screening of MOFs for gas separations. Coord. Chem. Rev. 2020;422; doi:https://doi.org/10.1016/j.ccr.2020.213470.
- Irwin JJ, Sterling T, Mysinger MM, et al. ZINC: a free tool to discover Chemistry for Biology. J. Chem. Inf. Model. 2012;52(7):1757–1768. doi:https://doi.org/10.1021/ci3001277.
- Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 09, Revision D.01. Wallingford (CT): Gaussian, Inc.; 2009.
- Becke AD. Density-functional exchane-energy approximation with correct asymptotic-behavior. Phys. Rev. A. 1988;38:3098-4000.
- Breneman CM, Wiberg KB. Determining atom-centered monopoles from molecular electrostatic potentials. The need for high sampling density in formamide conformational analysis. J. Comput. Chem. 1990;11(3):361–373. doi:https://doi.org/10.1002/jcc.540110311.
- Groom CR, Bruno IJ, Lightfoot MP, et al. The Cambridge structural database. Acta Crystallogr. Sect. B. 2006;72(2):171–179. doi:https://doi.org/10.1107/S2052520616003954.
- Rappe AK, Casewit CJ, Colwell KS, et al. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J. Am. Chem. Soc. 1992;114(25):10024–10035. doi:https://doi.org/10.1021/ja00051a040.
- Chen YF, Babarao R, Sandler SI, et al. Metal−organic framework MIL-101 for adsorption and effect of terminal Water molecules: from quantum mechanics to molecular simulation. Langmuir. 2010;26(11):8743–8750. doi:https://doi.org/10.1021/la904502 h.
- Agostoni V, Anand R, Monti S, et al. Impact of phosphorylation on the encapsulation of nucleoside analogues within porous iron(Iii) Metal-organic framework MIL-100(Fe) nanoparticles. J. Mater. Chem. B. 2013;1(34):4231–4242. doi:https://doi.org/10.1039/C3TB20653J.
- Llewellyn PL, Horcajada P, Maurin G, et al. Complex adsorption of short linear alkanes in the flexible metal-organic-framework MIL-53(Fe). J. Am. Chem. Soc. 2009;131(36):13002–13008. doi:https://doi.org/10.1021/ja902740r.
- Wilmer CE, Kim KC, Snurr RQ. An extended charge equilibration method. J. Phys. Chem. Lett. 2012;3(17):2506–2511. doi:https://doi.org/10.1021/jz3008485.
- Sigala PA, Ruben EA, Liu CW, et al. Determination of hydrogen bond structure in water versus aprotic environments To test the relationship between length and stability. J. Am. Chem. Soc. 2015;137(17):5730–5740. doi:https://doi.org/10.1021/ja512980 h.
- Coupry DE, Addicoat MA, Heine T. Explicit treatment of hydrogen bonds in the universal force field: validation and application for Metal-Organic frameworks, hydrates, and host-guest complexes. J. Chem. Phys. 2017;147(16):161705. doi:https://doi.org/10.1063/1.4985196.
- Wang J, Jin J, Li F, et al. Combined experimental and theoretical insight into the drug delivery of nanoporous metal-organic frameworks. RSC Adv. 2015;5(104):85606–85612. doi:https://doi.org/10.1039/C5RA12543J.